PJ

Poojaben Jayntibhai Bhimani

Active Director Designated Partner DIN 10406274
DIN 10406274 First appointment Nov 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Poojaben Jayntibhai Bhimani

Data last updated:

Poojaben Jayntibhai Bhimani is a Designated Partner at Distrimed Bioscience Llp (since 2023). The company operates in Business Services.

DIN 10406274
Primary Designation Designated Partner
Industry Business Services
First Appointment 28 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner28 Nov 20232023Active

Board colleagues of Poojaben Jayntibhai Bhimani

NameDINCompanyDesignation
Rajvi Rakesh Prajapati10406273Distrimed Bioscience LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Distrimed Bioscience Llp
Premium access

Shareholding and investment profile for Poojaben Jayntibhai Bhimani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poojaben Jayntibhai Bhimani

Poojaben Jayntibhai Bhimani currently holds 1 directorship: Distrimed Bioscience Llp (Designated Partner, since 28 Nov 2023).

Poojaben Jayntibhai Bhimani was first appointed on 28 Nov 2023 as Designated Partner at Distrimed Bioscience Llp.

The current boards of Poojaben Jayntibhai Bhimani's companies include Rajvi Rakesh Prajapati (Distrimed Bioscience Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available